A detailed history of Allworth Financial LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 192 shares of GH stock, worth $5,589. This represents 0.0% of its overall portfolio holdings.

Number of Shares
192
Previous 200 4.0%
Holding current value
$5,589
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$22.3 - $36.29 $178 - $290
-8 Reduced 4.0%
192 $4,000
Q2 2024

Jul 23, 2024

BUY
$16.07 - $31.84 $3,085 - $6,113
192 Added 2400.0%
200 $5,000
Q4 2023

Jan 24, 2024

SELL
$21.58 - $29.5 $1,963 - $2,684
-91 Reduced 91.92%
8 $0
Q3 2023

Oct 31, 2023

BUY
$25.8 - $39.97 $1,083 - $1,678
42 Added 73.68%
99 $2,000
Q2 2023

Jul 18, 2023

BUY
$20.94 - $38.01 $439 - $798
21 Added 58.33%
57 $2,000
Q1 2023

Apr 18, 2023

BUY
$22.92 - $33.76 $412 - $607
18 Added 100.0%
36 $0
Q4 2022

Jan 13, 2023

BUY
$25.44 - $59.78 $101 - $239
4 Added 28.57%
18 $0
Q3 2022

Oct 18, 2022

SELL
$43.66 - $61.0 $2,575 - $3,599
-59 Reduced 80.82%
14 $1,000
Q2 2022

Jul 13, 2022

BUY
$28.82 - $77.35 $2,103 - $5,646
73 New
73 $3,000
Q1 2022

Apr 22, 2022

SELL
$48.25 - $100.49 $7,334 - $15,274
-152 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$88.71 - $120.43 $6,032 - $8,189
68 Added 80.95%
152 $15,000
Q3 2021

Nov 02, 2021

BUY
$98.77 - $132.17 $8,296 - $11,102
84 New
84 $11,000
Q1 2021

Apr 29, 2021

SELL
$127.04 - $179.1 $3,684 - $5,193
-29 Closed
0 $0
Q4 2020

Jan 26, 2021

BUY
$99.96 - $135.93 $2,898 - $3,941
29 New
29 $4,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.98B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.